Cargando…
Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease
PURPOSE: Chronic obstructive pulmonary disease (COPD), a prevalent obstructive airway disease, has become the third most common cause of death globally. Xuanbai Chengqi decoction (XBCQ) is a traditional Chinese medicine prescription for the acute exacerbation of COPD. Here, we aimed to reveal the th...
Autores principales: | Wang, Yongan, Li, Na, Li, Qiuyi, Liu, Zirui, Li, Yalan, Kong, Jingwei, Dong, Ruijuan, Ge, Dongyu, Li, Jie, Peng, Guiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666724/ https://www.ncbi.nlm.nih.gov/pubmed/34916790 http://dx.doi.org/10.2147/COPD.S337181 |
Ejemplares similares
-
Effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome
por: Mao, Zhengrong, et al.
Publicado: (2016) -
The use of Xuanbai Chengqi decoction on monkeypox disease through the estrone-target AR interaction
por: Jiao, Yanqi, et al.
Publicado: (2023) -
Chemical composition and therapeutic mechanism of Xuanbai Chengqi Decoction in the treatment of COVID-19 by network pharmacology, molecular docking and molecular dynamic analysis
por: Fan, Liming, et al.
Publicado: (2022) -
Dachengqi Decoction alleviates intestinal inflammation in ovalbumin-induced asthma by reducing group 2 innate lymphoid cells in a microbiota-dependent manner
por: Liu, Zirui, et al.
Publicado: (2023) -
The Efficacy and Safety of Xinjia Xuanbai Chengqi Granules in Acute Exacerbation of COPD: A Multicentre, Randomised, Double-Blind, Controlled Trial
por: Qi, Ruihan, et al.
Publicado: (2022)